Exact Sciences schedules second quarter 2024 earnings call
08 Julho 2024 - 7:00AM
Business Wire
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of
cancer screening and diagnostic tests, today announced that the
company plans to release its second quarter 2024 financial results
after the close of the U.S. financial markets on July 31, 2024.
Following the release, company management will host a webcast and
conference call at 5 p.m. ET to discuss financial results and
business progress.
Second quarter 2024 webcast & conference call
details
Date:
Wednesday, July 31, 2024
Time:
5 p.m. ET
Webcast:
The live webcast can be accessed at
www.exactsciences.com
Telephone:
Domestic callers, dial 888-330-2384
International callers, dial +1 240-789-2701
Access code for both domestic and
international callers: 4437608
A replay of the webcast will be available at
www.exactsciences.com. The webcast, conference call, and replay are
open to all interested parties.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests,
Exact Sciences gives patients and health care professionals the
clarity needed to take life-changing action earlier. Building on
the success of the Cologuard® and Oncotype® tests, Exact Sciences
is investing in its pipeline to develop innovative solutions for
use before, during, and after a cancer diagnosis. For more
information, visit ExactSciences.com, follow Exact Sciences on X
(formerly known as Twitter) @ExactSciences, or find Exact Sciences
on LinkedIn and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240708342895/en/
Erik Holznecht Exact Sciences Corp.
investorrelations@exactsciences.com 608-800-6605
EXACT Sciences (NASDAQ:EXAS)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
EXACT Sciences (NASDAQ:EXAS)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024
